LIBROS
Avioli LV, ed. The osteoporotic syndrome: Detection, prevention and treatment (4.a ed). San Diego: Academic Press, 2000.
NUMEROS MONOGRAFICOS
Cannata J, Ortega F, eds. VII Simposio Internacional del Instituto de Investigación Nefrológica: Metabolismo óseo y polimorfismo del gen del receptor de la vitamina D. Nefrología 2001; 21: 45-60.
Cowell CT, Wüster C, eds. Analytic methods in clinical osteology. Useful predictors of long-term outcomes or a waste of time and money. Hormone Res 2000; 54 (Supl 1): 1-74.
Walker-Bone K, Dennison E, Cooper C. Osteoporosis. Rheum Dis Clin North Am 2001; 27: 1-180.
NUESTROS AUTORES
Montalbán J, Rico H, Cortés J, Pedrera JD. Masa cortical ósea y factores de riesgo para la osteoporosis en mujeres postmenopáusicas de nuestro medio. Rev Clin Esp 2001; 201: 16-20.
Espallargues M, Estrada MD, Sampietro L, Granados A. Cribado de la osteoporosis en las personas mayores. Med Clin (Barc) 2001; 116 (Supl 1): 77-82.
Armelles M, Martínez V, Medina A, et al. Consejo para la prevención de accidentes y caídas en las personas mayores. Med Clin (Barc) 2001; 116 (Supl 1): 106-111.
Fachinetti MM, Russo A. Aging and calcitriol regulation of IP3 production in rat skeletal muscle and intestine. Hormone Metab Res 2001; 33: 10-15.
Gussiye M, Terradas P, Yeste D, et al. Low bone mineral density values in adolescents and young adult Turner syndrome patients increase after long-term transdermal estradiol therapy. Hormone Res 2001; 54: 131-135.
Se ruega a los autores enviar una copia del trabajo para incluir su cita en esta Sección.
REVISIONES
Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Int Med 2001; 161: 1.161-1.172.
Recker RR, Heaney RP. The role of combination treatment for osteoporosis. J Clin Endocrinol Metab 2001; 86: 1.888-1.889.
Balestrieri A, Faustini H, Rochira V, Cerani C. Clinical implications and management of estrogen deficiency in the male. Clin Endocrinol 2001; 54: 431-432.
Huddlestrom J, Whitford KJ. Medical care of elderly patients with hip fractures. Mayo Clin Prod 2001; 76: 295-298.
Reginster JY, Christiansen C, Roux C, et al. Intermitent cyclic tiludronate in the treatment of osteoporosis. Osteoporosis Int 2001; 12: 169-177.
Johnell O, Oden A, Caulin F, Kanis JA. Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporosis Int 2001; 12: 207-214.
Huddlestrom JM, Witford KJ. Medical care of elderly patients with hip fractures. Mayo Clin Proc 2001; 76: 295-298.
Rauch F, Schoenau E. Changes in bone density during childhood and adolescence: an approach based on bone's biological organization. J Bone Miner Res 2001; 16: 597-604.
Rosier RN. Expanding the role of the orthopedic surgeon in the treatment of osteoporosis. Clin Orthop 2001; 385: 57-67.
Astrom AB, Puchalski CM, Sulmasy DP. Religion, spirituality and health care: social, ethical and practical considerations. Am J Med 2001; 110: 283-287.
Clarke R, Leonessa F, Welch JN, Skaar TC. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Review 2001; 53: 25-72.
LeBlanc ES, Janowsky J, Chan KBS, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001; 285: 1.489-1.499.
Altkorn D, Vokes T. Treatment of postmenopausal osteoporosis. JAMA 285: 1.415-1.418.
Fleisch H. Can biphosphonates be given to patients with fractures? J Bone Miner Res 2001; 16: 437-330.
Alexander C. Idiopatic osteoporosis: an evolutionary disadaptation? Ann Rheum Dis 2001; 60: 554-558.
Lane NE. An update on glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 2001; 27: 235-253.
Cheung AM. Post-liver transplantation osteoporosis. J Hepatol 2001; 34: 337-338. Gold DT. The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum Dis Clin North Am 2001; 27: 255-262.
Peichl P, Griesmacherb A, Marteau R, et al. Osteoporosis in systemic lupus erythematosus: prevention and treatment. Lupus 2001; 10: 227-232.
OTROS ARTICULOS DE INTERÉS
Lips P, Doung T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1.212-1.221.
Schwartz AV, Sellmeyer DE, Ensrud KE, et al. Older women with diabetes have an increased risk of fracture. A prospective study. J Clin Endocrinol Metab 2001; 86: 32-38.
Hrlfrich MH, Gerritsen EJA. Formation of non-resorbing osteoclasts from peripheral blood mononuclear cells of patients with malignant juvenile osteopetrosis. Br J Hemat 2001; 112: 64.
Nguten TV, Center JR, Sambrook PN, Esiman JA. Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women. The Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol 2001; 153: 587-595.
Schoon EJ, Müller MCA,Vermeer C et al. Low serum and bone vitamin K status in patients with longstanding Crhon's disease: another pathogenetic factor of osteoporosis in Crhon's disease Gut 2001; 48: 473-477.
Henini PF, Berlemann U, Kaufma M et al. Augmentation of mechanical properties in osteoporotic vertebral bones a biochemical investigation of vertebroplasty efficacy with differents bone cements. Eur Spine J 2001; 10: 164-171.
Lu Y, Genant HK, Shepherd J et al. Classifcation of osteoporosis based on bone mineral densities. J Bone Miner Res 2001; 16: 901-910.
Baron JA, Farhmard BY, Weiderpass E et al. Cigarette smoking alcohol consumption and risk of hip fracture in women. Arch In Med 2001; 161: 983-988.
Bauer DC, Ettinger B, Nevitt MC et al. Risk for fracture in woman with low serum levels of thyroid-stimulating hormone. Ann Int Med 2001; 134: 561-568.
Skripitz R, Apenberg P. Implant fixation enhancement by intermitent treatment with parathyroid hormone. J Bone Joint Surg (Br) 2001; 83-B: 437-440.
Cauley JA, Black DM, Barrett-Connor E et al. Effects of hormone replacement therapy on clinical fractures and heigh loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med 2001; 110: 442-450.
Zborowski JV, Talbott EO, Cauley JA. Polycystic ovary syndrome, androgen excess, and the impact on bone. Obstet Gynecol Clin North Am 2001; 28: 135-151.
Kasper MJ, Peterson MG, Allegrante JP. The need for comprehensive educational osteoporosis prevention programs for young women: results from a second osteoporosis prevention survey. Arthritis Rheum 2001; 45: 28-34.
Gillberg P, Johansson AG, Blum WF et al. Growth hormone secretion and sensitivity in men with idiopathic osteoporosis. Calcif Tissue Int 2001; 68: 67-73.
Stevens HG, Jacobs JW, Van Rijk PP, De Klerk JM. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin Biochem 2001; 34: 131-139.
Sen D, Keen RW. Methotrexate osteopathy demonstrated by technetium-99m hdp bone scintigraphy. Clin Nucl Med 2001; 26: 389-391.
Yosipovitch G, Hoon TS, Leok GC. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. Arch Dermatol 2001; 137: 477-481.
Gooren LJ, Lips P, Gijs L. Osteoporosis and androgen-depleting drugs in sex offenders. Lancet 2001; 357: 1208-1209.
Lewis SJ, Smith PE. Osteoporosis prevention in myasthenia gravis: a reminder. Acta Neurol Scand 2001; 103: 320-322.
Hauge EM, Mosekilde L, Melsen F, Frydenberg M. How many patients are needed? Variation and design considerations in bone histomorphometry. Bone 2001; 28: 556-562.
Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids.